Синяя социальная система управления закладками и публикациями.
Log in with your username.
Я забыл свой пароль.
Log in with your OpenID-Provider.
NICE has introduced new criteria for appraising end of life treatments. James Raftery looks at how they might affect availability by applying them to previously refused drugs